NCT06995131 (DEL-1 and IL-1) is a NA clinical trial of Del 1 in Diabetic Group (n=30), sponsored by Uşak University.

Who is sponsoring NCT06995131?

NCT06995131 is sponsored by Uşak University.

What drugs are being tested in NCT06995131?

Interventions in NCT06995131: Del 1, IL 17.

What condition does NCT06995131 study?

NCT06995131 studies Diabetic Group (n=30), Non-diabetic Group.

Is NCT06995131 still recruiting?

NCT06995131 is currently recruiting now. Last updated 5 June 2025.

Last reviewed 2025-06-05 · How we verify

NCT06995131: DEL-1 and IL-1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Aqueous Humor DEL-1 and IL-17 Levels in Diabetic Cataract Patients

Recruiting now NA Last updated 5 June 2025

What this trial tests

NA trial testing Del 1 in Diabetic Group (n=30) in 60 participants. Currently enrolling.

Timeline

1 May 2025

Primary endpoint
31 July 2025

15 August 2025

Quick facts

Lead sponsor	Uşak University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	screening
Enrollment	60
Start date	1 May 2025
Primary completion	31 July 2025
Estimated completion	15 August 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Del 1
IL 17

Conditions studied

Diabetic Group (n=30) — all drugs for Diabetic Group (n=30) →
Non-diabetic Group — all drugs for Non-diabetic Group →

Sponsor

Uşak University

Who can join

Adults 50 to 80, any sex, with Diabetic Group (n=30) or Non-diabetic Group. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

By comparing DEL-1 and IL-17 levels in the aqueous humor of diabetic cataract patients with the aqueous humor of non-diabetic patients, we aim to understand the biochemical effects of diabetes-related inflammatory processes in the eye.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Uşak University trials

Trials by the same sponsor.

NCT07356362 — High-power Laser Therapy for Notalgia Paresthetica. · NA · not yet recruiting
NCT07328360 — The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica · NA · recruiting
NCT07276477 — Inspiratory Muscle Training After Stroke · NA · recruiting
NCT07296380 — Manual Therapy Behavior Scale in Physiotherapists · enrolling by invitation
NCT07296367 — Physiotherapy and Disaster · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06995131 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Uşak University
Last refreshed: 5 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06995131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing